H
Henan Sinotech Biotechnology
A joint-stock company approved by the provincial government in the animal husbandry industry
About Henan Sinotech Biotechnology
Celnovte Biotechnology Co., Ltd., established in 2010, operates as a specialized developer and manufacturer of pathological diagnostic reagents and instruments. The company is headquartered in Zhengzhou, China, with a global structure that includes a reagent and instrument development center in Rockville, MD, USA, an instrument R&D subsidiary in Shenzhen, a research-use product development arm in Suzhou, and manufacturing facilities in Zhengzhou.
The company's business model is centered on the development, production, and distribution of a comprehensive portfolio for the in-vitro diagnostics (IVD) market, with a focus on oncology pathology. Revenue is generated through the sale of its products to a client base that includes over 2,300 hospitals in China and a distribution network spanning more than 40 countries. Celnovte also engages in OEM/ODM partnerships, offering customized solutions and leveraging its more than 10 years of experience in pathology instrument design.
Celnovte's product offerings are extensive, covering immunohistochemistry (IHC), in-situ hybridization (ISH), histology, molecular diagnostics, cytology, and digital pathology. Key technologies include the MicroStacker™ IHC detection system, known for its high sensitivity and specificity, and the PolyStacker™ technology, which significantly reduces the turnaround time for frozen section IHC experiments to as little as 10 minutes. Additionally, its SuperISH™ RNA in-situ hybridization technology allows for RNA target detection at a single-molecule level. The company also manufactures fully automated instrumentation, such as IHC stainers, H&E stainers, special stainers, and digital slide scanners. A notable achievement has been the installation of over 800 automated IHC stainers worldwide since their launch in 2018.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- China
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 53.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2022 | $14M | $55M | Puhua Capital · Henan Gaochuang · Henan Zhongyuan Lianchuang Investment Fund Management · Gaoxin Industrial Investment | ↗ |
Growth signals
Latest recorded traffic for Henan Sinotech Biotechnology is 700 monthly website visits, up 311.8% over the last three months. Henan Sinotech Biotechnology's team grew 35.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Henan Sinotech Biotechnology in its local ecosystem
The Henan Sinotech Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- PCPuhua Capital
- HGHenan Gaochuang
- HMHenan Zhongyuan Lianchuang Investment Fund Management
- GIGaoxin Industrial Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Henan Sinotech Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Henan Sinotech Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








